Where does Kevin Ryan work?

Kevin Ryan is Founder & CEO at AlleyCorp and Board director at Ensage and Board director at Conduce, Inc./DE and Board director at Affect Therapeutics.

What check size does Kevin Ryan write?

Kevin Ryan typically writes checks of $1M.

What boards does Kevin Ryan sit on?

Kevin Ryan holds tracked board seats at Affect Therapeutics, Conduce, Inc./DE, DMG Practice Management Solutions, Ensage, Nomad Health, Pearl Health, RippleMatch, Unified Physician Management Holdings, Vault Laboratories, Inc..

Where did Kevin Ryan go to school?

Kevin Ryan studied at INSEAD (MBA); Yale University (BA, Economics); Chagrin Falls High School.

Kevin Ryan

Investor

Founder & CEO at AlleyCorp · Founder & Investor, AlleyCorp at GATHER VENTURES · Board director at Ensage · Board director at Conduce, Inc./DE · Board director at Affect Therapeutics

New York, New York

Writes $1M checks · typically $1M

Find your path to Kevin

238 people in our graph share verified history with Kevin — schools, employers, funds. One of them is your warm intro.

Laura BuhlerunlockedKevin: together at Gilt Groupe (2012–2016)

×5Kevin: together at MongoDB

×4Kevin: together at AlleyCorp

Kevin: together at Yale University

About

Kevin Ryan is a founder-operator who co-founded DoubleClick, Business Insider and MongoDB, and uniquely originates ideas internally while recruiting outside CEOs chosen for the precise skills each business requires.

Contact· self-published, not guessed

k•••@alleycorp.comreveal

Likely emails· guessed from name + firm domain, not firm-published

Invests in

ConsumerDeep TechEnterprise SoftwareFintechHardwareHealthtech

Board director at Ensage

Intro paths

→

In turn, Kevin can intro founders to Ensage's investors below.

Ensage's investors · 1

AlleyCorpNew York · $1M – $5M checks · since 2022

Board director at Conduce, Inc./DE

Intro paths

→

In turn, Kevin can intro founders to Conduce, Inc./DE's investors below.

Conduce, Inc./DE's investors · 1

AlleyCorpNew York · $1M – $5M checks · since 2024

Board director at Affect Therapeutics

Intro paths

→

In turn, Kevin can intro founders to Affect Therapeutics's investors below.

Affect Therapeutics's investors · 9

AlleyCorpNew York · $1M – $5M checks · since 2023 Allumia VenturesSeattle · $5M – $15M checks · since 2025 Artis VenturesSan Francisco · $50K – $25M checks · since 2023 City LightNew York · $1M – $6M checks Kapor CapitalOakland · $100K – $1M checks LifeArc VenturesLondon · since 2023 National Institutes of Health (NIH)since 2021 Samsung NextSan Jose · $100K – $5M checks · since 2023 What If VenturesFrisco · since 2023

Co-founders at Affect Therapeutics

Jeff DeFlavioCo-founder

Experience

AlleyCorpFounder & CEOcurrent2007 — presentNew York City Metropolitan Area
Transcend TherapeuticsCo-Founder and Chairmancurrent2021 — presentNew York, United States
Pearl HealthFoundercurrent2021 — presentNew York, New York, United States
Zola.comFounder & Chairmancurrent2013 — presentGreater New York City Area
MongoDB, Inc.Founder & Chairman2008 — 2019New York City Metropolitan Area
Gilt GroupeFounder & Chairman2007 — 2016New York City Metropolitan Area
Business InsiderFounder & Chairman2007 — 2015New York City Metropolitan Area
DoubleClickPresident, then CEO1996 — 2005New York City Metropolitan Area

Skills & more

Start-upsE-commerce80Entrepreneurship73Strategic Partnerships90Online Advertising63Venture Capital28Product Management24Online Marketing33Mobile Applications26Web Analytics23

Languages English · French

From Kevin's professional profile.

Deals · 6

Conduce, Inc./DEBoard seat

via AlleyCorp · filed Mar 2024 · $4M raise

Unified Physician Management HoldingsBoard seat

via AlleyCorp · filed Jan 2024 · $5.3M raise

Vault Laboratories, Inc.Board seat

via AlleyCorp · filed Jun 2023 · $8M raise

EnsageBoard seat

via AlleyCorp · filed Aug 2022 · $1.5M raise

DMG Practice Management SolutionsBoard seat

via AlleyCorp · filed Jan 2022 · $23.7M raise

Nomad HealthBoard seat

via AlleyCorp · filed Oct 2021 · $38M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

Affect Therapeutics Pearl Health RippleMatch

Investor

AnvylAtlas ObscuraBarte BluegroundCambrian Asset ManagementCapable HealthChordCortinaEverphoneGreat JonesKamaKidPassKnockLaunchCenter 39LazoMartiMojo MotorsOye Pearl Health PrintifyProperlyRippleMatchSoBanHang (Finan Pte. Ltd.)TileDBUaláUpwage ValidioValon TechnologiesVerb Energy

Sources: SEC Form D filings · curated public sources.

Colleagues at AlleyCorp

Abe Murray

General Partner at AlleyCorp

Alex Martin

Investor at AlleyCorp

Alexi Nazem, MD

General Partner at AlleyCorp

Alison Hill

Chief of Staff at AlleyCorp

Brannon Jones

Principal at AlleyCorp

Bree PiperWilliams

Events Manager at AlleyCorp

Brenton Fargnoli

Partner at AlleyCorp

Catherine Diffley

Head of Hospitality & Real Estate at AlleyCorp

Network7

Abe MurrayScout

General Partner at AlleyCorp

Alexander BusseScout

Managing Partner at NXTP

Brenton FargnoliScout

Partner at AlleyCorp

Brian McGrathScout

General Partner at Ribbit Capital

Cherry FreemanScout

Founder & General Partner at Hiro Capital

Evonne JohnsonScout

Investor at Inception Studio Capital

Gale WilkinsonScout

Managing Partner at Vitalize Venture Group

Investors connected to Kevin in public investor directories — a warm-intro map.

Frequently asked questions

Who is Kevin Ryan?: Kevin Ryan is a founder-operator who co-founded DoubleClick, Business Insider and MongoDB, and uniquely originates ideas internally while recruiting outside CEOs chosen for the precise skills each business requires.
Where does Kevin Ryan work?: Kevin Ryan is Founder & CEO at AlleyCorp and Board director at Ensage and Board director at Conduce, Inc./DE and Board director at Affect Therapeutics.
What does Kevin Ryan invest in?: Kevin Ryan invests in Consumer, Deep Tech, Enterprise Software, Fintech, Hardware, Healthtech.
What check size does Kevin Ryan write?: Kevin Ryan typically writes checks of $1M.
What boards does Kevin Ryan sit on?: Kevin Ryan holds tracked board seats at Affect Therapeutics, Conduce, Inc./DE, DMG Practice Management Solutions, Ensage, Nomad Health, Pearl Health, RippleMatch, Unified Physician Management Holdings, Vault Laboratories, Inc..
What companies has Kevin Ryan invested in?: Investments tracked here include Anvyl, Atlas Obscura, Barte, Blueground, Cambrian Asset Management, Capable Health, Chord, Cortina, Everphone, Great Jones, Kama, KidPass, and 17 more.
Where did Kevin Ryan go to school?: Kevin Ryan studied at INSEAD (MBA); Yale University (BA, Economics); Chagrin Falls High School.